In invasive bladder cancers, it has been demonstrated that ASS-1 loss promotes cancer cell survival through GCN2 expression [13], and that administration of ADI-PEG-20 causes apoptosis through GCN2/ATF4 mediated CHOP activation. This evidence concerns the gene ASS1 and cancer.